Intralipid causes falsely increased glucose concentrations with the Hemocue glucose analyzer

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 5, 2010, Pages 737-738

  Heijboer, Annemieke C ^a   Bouman, Anna A ^a   Blankenstein, Marinus A ^a   Roelandse Koop, Elianne A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood glucose analyzer; Glucose201DM; Intralipid; Point of care testing (POCT)

Indexed keywords

INTRALIPID;

GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPOGLYCEMIA; LETTER; METABOLIC DISORDER; NEWBORN; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PRIORITY JOURNAL;

BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIAGNOSTIC ERRORS; FAT EMULSIONS, INTRAVENOUS; HUMANS; INFANT, NEWBORN;

EID: 77952532120     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.126     Document Type: Letter

References (4)

1. Heijboer AC, Otten JH, Jelles WJ, Blankenstein MA, Vroonhof K. Importance of sample size in hospital point-of-care glucose measurements. Clin Chem Lab Med 2008;46:874-5.
2. Bellini C, Serra G, Risso D, Mazzella M, Bonioli E. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med 2007;45:1549-54.
3. Darby D, Broomhead C. Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V. Ann Clin Biochem 2008;45:289-92.
4. Ashworth L, Gibb I, Alberti KG. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 1992;38:1479-82.